Oxford Biomedica Plc (OXBDF)
9.00
+0.95
(+11.80%)
USD |
OTCM |
May 07, 13:33
Oxford Biomedica SG&A Expense (TTM) : 48.35M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Silence Therapeutics Plc | 22.34M |
| Adaptimmune Therapeutics Plc | 90.50M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| NuCana Plc | 10.74M |
| Autolus Therapeutics Plc | 131.95M |